Sept 29 (Reuters) – HUTCHMED (China) said on Tuesday Anglo-Swedish drugmaker AstraZeneca had filed an application with the US Food and Drug Administration for approval of the ORPATHYS-TAGRISSO
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
CHINA PBOC EXPECTED TO SET YUAN MID-POINT AT 6.7177 PER DOLLAR - REUTERS ESTIMATE (The…
By Echo Wang and Aditya Soni Sept 28 (Reuters) - Anthropic plans to caution potential…
By Echo Wang and Aditya Soni Sept 28 (Reuters) - Anthropic plans to caution potential…
* Prospectus says models could resist shutdown, conceal information and exhibit behavior resembling blackmail *…
By Echo Wang, Ross Kerber and Jeffrey Dastin Sept 28 (Reuters) - Anthropic has long…
By Chandni Shah Sept 28 (Reuters) - Tether's USDT stablecoin has become a "significant financial…